Microarray technologies have both fascinated and frustrated the toxicological community since their introduction about a decade ago. Fascination arose from the possibility offered by the technology to gain a profound incite into the cellular response to chemically mediated stress, and the potential that this genomic signature would be indicative of the biological mechanism by which that stress was induced.
Abstract.
Microarray technologies have both fascinated and frustrated the toxicological community since their introduction about a decade ago. Fascination arose from the possibility offered by the technology to gain a profound incite into the cellular response to chemically mediated stress, and the potential that this genomic signature would be indicative of the biological mechanism by which that stress was induced.
Frustrations have arisen primarily from technical factors such as data variance, the requirement for the application of advanced statistical and mathematical analysis and difficulties associated with actually recognising signature gene expression patterns, and discerning mechanisms. Toxicogenomics was predicted to make toxicological assessment and extrapolation easier, faster and cheaper. The reality has been that toxicogenomics is difficult. However, its potential when properly applied has been indicated by some well designed toxicogenomics studies, particularly in the differentiation of genotoxins from non-genotoxins. Technology waits though for no man. While the toxicological community has been working to apply transcriptomics (mRNA levels) in toxicology the technology has moved beyond this application into new arenas. Some have application to toxicology and are reviewed here, except transcriptomics which has been extensively written about before. Discussed are the Introduction Using microarrays to measure mRNA levels for genes across the whole or large parts of the genome has become a familiar technology in recent years. There are still many challenges associated with the interpretation of the data obtained, but the actual technology for data generation has matured with oligo based arrays in various formats becoming the de facto standard. Recent data from the USFDA has confirmed that the platforms are becoming robust, and that quantitatively similar data can be obtained across platforms [1] .
The determination of mRNA levels for many genes simultaneously has been the major application of microarray technology [2] . However, to consider that this is their only application in regulatory and investigative toxicology is to take a myopic view of the potential application of this important methodology. The microarray format is as adaptable as its ancestor hybridization technologies and useful in all experimental applications involving hybridization. In this article we shall explore some of these applications, their role in making toxicological assessments, and position in the drug development pipeline.
As the use of microarrays for the determination of mRNA levels has been very well presented in a large number of articles it will not be addressed here. Rather this article will focus on some of the less explored applications of microarray technology and their application in toxicological assessment. The various applications will be presented in overview under separate sub-headings with the potential application to toxicological assessment dealt with at the end of each. The potential spectrum of microarray applications in toxicological assessment from the genome to assessment of mRNA translation is shown in figure 1. Also this article will be restricted to nucleic acid based arrays rather than those made with proteins or designed for high throughput transfections [3] . This focus though does not imply that non nucleic acid microarrays, such as those employing proteins as targets do not have application in the understanding of toxicology. Indeed there are profound opportunities for the use of non-nucleic acid microarrays in toxicological research.
What should be apparent is that although many articles have been written on the application of the microarrays in toxicology we are really still only at the initial stages of realising their true potential [4, 5] .
Array comparative genome hybridisation (ArrayCGH)
Outside of the determination of mRNA levels one of the first alternative applications of microarray technology was in the determination of gene changes (amplification and deletion) in the genome [6] . This method has recently been used to measure global variation in copy number through the human genome [7] . The process of determining chromosomal changes is essentially the same as that of measuring mRNA transcript levels, except that the probe is genomic DNA (gDNA) and not mRNA [8, 9] . Hybridization and data collection occurs in a similar manner to that used for expression microarrays with (for a two colour system) probes from a control and test system hybridised to the same microarray to produce the familiar red and green spot image. The ratio of fluorescent dye in the hybridized spot indicates either an amplification or deletion in the genome. These data can be plotted against the chromosomal location of the probe to produce a map of the chromosome. An example of this can be seen in figure 2 where hybridisation of gDNA from a rat with a gene mutation giving rise to a Wilson's disease type was hybridised against that from a control Fischer rat. A deletion of one gene (cadherin 11) can be seen. The areas of the genome assayed in ArrayCGH are dependent on the targets on the microarray. It is often informative to compare the data obtained from an ArrayCGH assay with that of expression level assayed by measuring mRNA levels which can indicate whether the genes have been amplified whole, and if the increased copy number is reflected in the amount of mRNA transcript. An example of this application is shown in figure 3 for doxorubicin resistance cells where the BAK1 and ABCB4 genes are shown amplified but not overexpressed, MMP1 is overexpressed but not amplified but ABCB1 is both amplified and overexpressed. Further ABCB1 and ABCB4 are adjacent on human chromosome 7 and so while both have probably been amplified as a cassette only ABCB1 has been amplified in a manner which has led to its overexpression [11] . Use of the Array CGH technique has demonstrated the diversity that exists of copy number in the human genome [7] . Such genetic change affects resistance and susceptibility to toxicity and understanding the effect of genome variation could have a fundamentally important application in the assessment of drug efficacy and safety.
These data also indicate that there is an important need to use arrayCGH to characterise cells and animal strains used for testing purposes. This has not been carried out to date but could yield valuable data that would inform on the resistance and susceptibility of strains and species, and also act as a reference for confirming the genomic stability of cells used for testing purposes in culture.
Epigenetic modification.
The recent sequencing of the human epigenome for three chromosomes has brought this application of microarray technology into sharp focus [15] . For toxicology there is potential both for understanding how drugs and chemicals alter DNA methylation patterns in cells and how these might affect toxicity and, second, in elucidating how epigenetic changes affect gene expression and in turn susceptibility and resistance to toxicity. Most work in genetic susceptibility has focussed on polymorphic mechanisms, but the small amount of epigenetic work in toxicology published indicates that this is substantial contributory mechanism to the genetically modulated response to xenobiotic exposure [16] .
One means of epigenetic modulation is via the differential cytosine methylation. This can be assessed using microarray technology by first breaking up the DNA using either a mechanical or enzymatic means followed by immunoprecipitation of those fragments methylated using an antibody against 5-methylcytosine. A microarray There is however another potentially important role for epigenetics in toxicology; in the understanding the mechanisms of transgenerational toxicology. What is meant by transgenerational toxicology is genome alteration, which may give rise to a phenotype, and is present in progeny as a result of germline transmission from the exposed parents [18] . This is different from reproductive toxicity where the toxicity arises in the foetus as a result of direct xenobiotic exposure in the uterus.
Transgenerational genome instability arising from chemical exposure has been indicated by minisatellite mutation in both individual sperm and somatic cells of first generation mice where the father has been exposed to radiation or genotoxins [19, 20] .
Apart from transgenerational effects modification of epigenetic status in the embryo through maternal exposure may have important long term effects for the foetus and subsequent generations. One such example is diethylstilboestrol where effects are then seen in the subsequent male and female lineages after exposure in utero [21] .
The effects observed in the male lineage mice were an increased incidence of proliferative lesions of oestrogen target tissues and tumours of the reproductive tract.
In females an increased incidence of uterine adenocarcinoma was observed.
Transmission was only investigated through the female germ line. The mechanism of this effect was not investigated but previous work from this group has shown an effect of DES on DNA methylation patterns Thus the hypothesis that altered methylation may be the mechanism is entirely plausible [22, 23] . The demonstration of the inheritance to the F2 and F3 generations in the mouse of vinclozolin induced DNA methylation changes lends weight to the hypothesis [24] .
Using microarrays containing probes for promoter regions combined with immunoprecipitation of methylated DNA offers profound opportunities for the study of The methodology of ChIP analysis is very similar to that used for epigenetic analysis.
A microarray containing gene promoter region target sequences is required, as it is for the assessment of epigenetic analysis. Similarly an immunoprecipitation step is involved. The difference is that while the assessment of epigenetic status requires the use of an antibody against 5-methylcytosine, ChIP analysis requires an antibody against the transcription factor of interest. As there are two proteins involved, the antibody and the transcription factor, as well as the DNA fragment, it is necessary to chemically cross link the transcription factor to the DNA before immunoprecipitation [25] . Transcription rate analysis.
The nuclear run-on assay has been employed to assess whether a gene is increased in its transcriptional rate in a certain circumstance eg: after chemical exposure. For example the nuclear run on assay has been used to show that transcription of the ABCB1 gene can be increased after chemical exposure in the liver [28] . It should be possible to undertake such an analysis on a global scale using a microarray. Indeed a crude version of a microarray (the dot blot) has always been employed for this assay so the microarray would mean just an increase in the number of genes being probed.
The principle of the assay would then be that nuclei would be isolated from untreated and exposed cells or tissues. These nuclei would then be allowed to finish making All of the above microarray based assays give information about the upstream events that can lead to differential mRNA levels. The subject of the determination of gene expression by measurement of mRNA levels is not going to be covered in this article for the reasons explained in the introduction. One of the criticisms though often levelled at the assessment of mRNA levels is that measurement has little application in mechanistic toxicological assessment because 'only proteins matter' and there is no evidence that the mRNA is translated into protein in a quantitative manner. Thus, it could be that a gene is increased in its transcriptional regulation resulting in an increased mRNA level, but that this does not per se lead to an increase in its protein level. Addressing this question is difficult because of limitations in technologies.
Proteomic techniques do not have the dimensionality of genomic techniques due the inherent problems of 2D gel resolution. Even when a protein can be measured the problems of quantification and of quantification methods, the necessity of measuring actual number of molecules (which is usually not done) and other technical factors make any quantitative comparison of data from genomics and proteomics techniques notoriously difficult, or impossible. Biochemically the new investigation area of the role of microRNA (miRNA) in the cell (see section following) has shown that these species can target mRNA molecules for storage in P bodies within the cytoplasm [29] . These can be potentially retrieved and used for rapid translation and thus there is a possibility of an increase in protein level without new transcription. This is most likely a fast response mechanism though and in the longer term new transcription becomes necessary. Data from our laboratory (Alexandra Paun personal communication in collaboration with Richard Currie of Syngenta CTL) has indicated that phenobarbital causes an increase in translation in rat liver which is dose and time dependent. Using the technique below we have shown that many of the genes which are transcriptionally increased in expression are also translated more actively indicating that both transcription and translation control mechanisms are important in the cellular response to xenobiotics.
There therefore appears to be a fundamental requirement to understand the effect of chemicals on mRNA translation. In particular if chemical exposure can lead to mRNA species being differentially translated as the cells increase their requirement for particular proteins to counter xenobiotic effects.
The assay mentioned above which has been developed in our laboratory and elsewhere [30] seeks to resolve both the questions of 'is the mRNA translated?' and 'is the mRNA differentially translated?' The assay relies on separation from whole RNA the mRNA with ribosomes attached by density, the polysomal fraction. The mRNA without attached ribosomes combines with the ribosomal RNA itself is the monosomal fraction (figure 4). An assumption is made mRNA found in the polysomal fraction is being actively translated, and there is a linear relationship between the number of ribosomes bound to the mRNA and the amount of protein formed. With this assumption the basis of the assay is in fact very simple. A cytoplasmic cell extract is prepared in which the ribosomes are stabilised on the mRNA through the use of the translation inhibitor cycloheximide. This is then layered onto a continuous sucrose density gradient and centrifuged. The proteins fail to enter the gradient and remain in a layer at the top. The mRNA species band through the gradient according to their density, and their density is dependent on the number of ribosomes bound.
Due to its higher density the polysome fraction finds density equilibrium at higher sucrose concentrations, and the monosome fraction at the lower sucrose concentrations. These gradients can then be unloaded using a collection apparatus with continuous monitoring at 254 nm allowing the profile of the separation to be determined and the fractions collected. The RNA can be isolated from the collected fractions and obtained is a series of RNA fractions from the heavy polysomal layers through to the lighter polysomal layers and the monosomes.
Either alone, or by pooling, the mRNA content of each of the fractions can then be assessed for mRNA content and diversity using a microarray containing consensus sequences for gene coding regions. Careful reference of the ratio of RNA in the monosome layers of two systems compared with that in the polysome layers allows the question 'is an mRNA species differentially translated in this system?' to be addressed [31] . The question of 'is an mRNA translated' is answered more simply by comparing the proportion in the polysome fraction with that in the monosome fraction.
As the RNA has been fractionated in this method care needs to be taken both with the amount used for hybridization and the method employed for normalization of the data. We use the assumption of majority non differential translation as the basis for normalisation. To achieve this on a two colour microarray the monosome fractions of the two samples are hybridised together on one microarray, and the polysomes from the same two samples on another.
It is not possible to normalize between polysomal fractions from control and treated tissues because this fails to correct for the amount of mRNA present in the sample for any particular species which could be altered due to differential transcription.
Comparison of the polysomal fractions only would lead to the massive likelihood of calling a gene differentially translated between two samples when it is in fact just being differentially expressed.
The approach of density RNA fractionation with microarrays has been used in fundamental biology to understand translational changes during spermatogenesis and cancer progression but remains underutilised in toxicology [32, 33] . However a few studies have indicated its potential application for example the translational response to redox stress in yeast and in mammalian cells to UV light [34, 35] .
Shenton et al showed that in yeast hydrogen peroxide (H 2 O 2 ) to concentrations of 2.0 mM causes a suppression of global translation. Using microarrays in the manner described above the effect of H 2 O 2 on specific genes was determined. At low concentrations (0.2mM) of H 2 O 2 there was specific upregulation of the translation of transcripts associated with membrane transport and iron regulation amongst others and at 2.0 mM H 2 O 2 transcripts associated with ribosome biogenesis were upregulated perhaps indicating the importance to the cell of maintaining its translational capability in the face of a substantial toxic insult [35] .
For the toxicity profiling with the aim to identify types of potential toxicity in novel agents there is not requirement to assay for translation. Whether a gene is translated, or not, is of no consequence for this analysis where it is only the pattern of gene expression that is required for database matching. However for an understanding of the mechanisms of toxicity and appropriate risk assessment first understanding whether there is a change in the protein complement of the treated system and whether this is per se regulated is of primary importance. miRNA One of the main control methods of gene translation occurs through the recently recognised microRNA species (miRNA) [36] . These miRNA species are mainly transcribed from the genome by RNA polymerase II though some transcription from RNA polymerase III may occur [37, 38] . The immature transcripts then undergo processing in the nucleus and cytoplasm to give rise to a 21-23nt miRNA molecule which, by interaction the RISC complex can control the translation of mRNA species against which it has a degree of homology [39] .
For toxicology there are some interesting aspects to these miRNA speices. Firstly they are transcribed from polycistronic regions and the control of the transcription appears to be very similar to that used for protein coding genes [37] . This implies that these genes may well be differentially regulated under the influence of chemicals which could then substantially change the translational profile of the cell. Second each miRNA species has an effect on the translation of many mRNA species and so a change in its level of expression could substantially affect the protein complement of the cell by altering the mRNA translation and lead to profound responses to chemical exposure. Finally, because of the potential control of the polycistronic regions at the transcriptional level they form an expression profile in a similar manner to mRNA species. Therefore the pattern of their expression could be potentially used to identify the type of toxicity which may be associated with the xenobiotic exposure.
Such miRNA profiling has been shown to differentiate cancer types and the same could occur for different xenobiotic exposures [40] .
To assess the expression of the miRNA species using microarrays there are some technical challenges to overcome. First, if there is a desire to assess the mature miRNA forms only then it is necessary to use a RNA tailing method for the labelling because the miRNA species are too short for conventional labelling techniques.
Conventional random primer labelling techniques can though be used to label the immature forms of the miRNA. Second, as the miRNA species are short it is often necessary to place targets on the microarray which contain modified nucleotides called locked nucleic acid nucleotides. These have the effect of making the hybridization more like an RNA/RNA hybridisation which has a higher melting temperature and thus gives rise to an increased stability and sensitivity [41] . Similarly the role of epigenetics in either conferring differential susceptibility or in mechanisms of toxicity should be explored. The data available indicating the involvement of epigenetic modification with the transgenerational toxicity of DES suggests this is an area of importance. Once again the samples from a short exposure could be used with appropriate microarray techniques to assess epigenetic change. Single cell minisatellite analysis could be carried out to show any genome instability which may be associated with epigenetic change. Finally the role of translation as a primary response to cellular stress is becoming apparent. Translation and miRNA analysis on the same samples from the short term exposure studies could be carried out to discern if any xenobiotic related effect on translation has occurred, and if this is mediated through differential miRNA expression.
For mechanistic understanding which may be necessary for an appropriate risk assessment then ChIP and transcriptional analysis could be carried out. Data from the transcriptome and translational assays would indicate if there was a requirement for these assays.
Therefore microarrays have potential application both in recognition and understanding of toxicity from xenobiotics. The challenge has been, is now, and for the foreseeable future will be, not so much use of the technology but data interpretation. These technologies have exciting potential in toxicology but also bring with then the challenge of data analysis and then integration for real success to be achieved. Translationally inhibited mRNA species are separated on a polysome gradient.
Those mRNA species with more ribosomes attached sediment at the higher densities with the UV trace showing the separation between monosomes and polysomes.
